Categories

Business Ideas
Business Opportunities
Corporate
Home Business
International Business
Management
Online Business
Public Company
Public Relations
Small Business

Popular Articles

Stocks, metals decline as China curbs lending
Stocks fell around the world, driving the MSCI Emerging Markets Index down the most in three weeks, and metals declined after China moved to curb lending. The yen dropped after Japan’s new finance minister said he would welcome a weaker currency.

Chandrayaan-II will be a technical challenge: Mission director
India’s second mission to Moon ‘Chandrayaan-II’, expected to be launched in 2013, has many challenges for scientists and engineers, mission director M Annadurai said today.

News of the day

Index closes below 17,000
Investors today pulled down the stock market benchmark Sensex below 17,000 points-level, as they sold banking, oil and gas and state-run companies’ shares to make profits.
Small Business

Aurobindo back in black with Rs 103 cr profit

Aurobindo Pharma, Hyderabad-based manufacturer of generic and active pharmaceutical ingredients reported a net profit of Rs 103.2 crore for the quarter ended September 30, 2009, as against a net loss of Rs 38.4 crore during the corresponding period last year. Revenues were up 24.42 per cent to Rs 882.64 crore as compared with Rs 709.4 crore last year. - Aurobindo gets nod to market 2 more products in S Africa - Bharat Biotech"s "INDIRAB" vaccine sales doubles - Aurobindo gets US FDA nod - Suven Life"s drug discovery achieves milestone - Aurobindo Pharma receives Swissmedic approval - Aurobindo Pharma receives Swissmedic approval for cefepime for injection The company made a forex gain of Rs 3.7 crore during the quarter as against a loss of Rs 85.3 crore last year. Formulations sales increased 39.4 per cent to Rs 445.2 crore during the period as compared with Rs 319.3 crore, managing director K Nithyananda Reddy said in a release. Aurobindo had three abbreviated new drug applications and 16 dossier filings during the quarter.


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009